8.75 USD
+0.01 (+0.11%)
ChartMill assigns a Buy % Consensus number of 49% to SMED. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.52. This target is -14.03% below the current price.
SMED was analyzed by 9 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about SMED.
In the previous month the buy percentage consensus was at a similar level.
SMED was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-06-28 | Barrington Research | Maintains | Outperform |
| 2021-04-29 | HC Wainwright & Co. | Maintains | Buy |
| 2021-04-26 | Roth Capital | Maintains | Buy |
| 2021-03-30 | Stifel | Maintains | Buy |
SHARPS COMPLIANCE CORP / SMED FAQ
What is the average price target for SHARPS COMPLIANCE CORP (SMED) stock?
9 analysts have analysed SMED and the average price target is 7.52 USD. This implies a price decrease of -14.03% is expected in the next year compared to the current price of 8.75.
How do analysts rate SHARPS COMPLIANCE CORP (SMED)?
The consensus rating for SHARPS COMPLIANCE CORP (SMED) is 48.8889 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
How many analysts have analysed SHARPS COMPLIANCE CORP (SMED)?
The number of analysts covering SHARPS COMPLIANCE CORP (SMED) is 9.